Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review

Alzheimer’s disease (AD) is a heterogeneous degenerative brain disorder with a rising prevalence worldwide. The two hallmarks that characterize the AD pathophysiology are amyloid plaques, generated via aggregated amyloid β, and neurofibrillary tangle, generated via accumulated phosphorylated tau. At...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hani Sabaie, Nazanin Amirinejad, Mohammad Reza Asadi, Abbas Jalaiei, Yousef Daneshmandpour, Omidvar Rezaei, Mohammad Taheri, Maryam Rezazadeh
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/a83098d4e64344e19aa3f308ce936fb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a83098d4e64344e19aa3f308ce936fb7
record_format dspace
spelling oai:doaj.org-article:a83098d4e64344e19aa3f308ce936fb72021-12-01T01:31:09ZMolecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review1663-436510.3389/fnagi.2021.742242https://doaj.org/article/a83098d4e64344e19aa3f308ce936fb72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnagi.2021.742242/fullhttps://doaj.org/toc/1663-4365Alzheimer’s disease (AD) is a heterogeneous degenerative brain disorder with a rising prevalence worldwide. The two hallmarks that characterize the AD pathophysiology are amyloid plaques, generated via aggregated amyloid β, and neurofibrillary tangle, generated via accumulated phosphorylated tau. At the post-transcriptional and transcriptional levels, the regulatory functions of non-coding RNAs, in particular long non-coding RNAs (lncRNAs), have been ascertained in gene expressions. It is noteworthy that a number of lncRNAs feature a prevalent role in their potential of regulating gene expression through modulation of microRNAs via a process called the mechanism of competing endogenous RNA (ceRNA). Given the multifactorial nature of ceRNA interaction networks, they might be advantageous in complex disorders (e.g., AD) investigations at the therapeutic targets level. We carried out scoping review in this research to analyze validated loops of ceRNA in AD and focus on ceRNA axes associated with lncRNA. This scoping review was performed according to a six-stage methodology structure and PRISMA guideline. A systematic search of seven databases was conducted to find eligible articles prior to July 2021. Two reviewers independently performed publications screening and data extraction, and quantitative and qualitative analyses were conducted. Fourteen articles were identified that fulfill the inclusion criteria. Studies with different designs reported nine lncRNAs that were experimentally validated to act as ceRNA in AD in human-related studies, including BACE1-AS, SNHG1, RPPH1, NEAT1, LINC00094, SOX21-AS1, LINC00507, MAGI2-AS3, and LINC01311. The BACE1-AS/BACE1 was the most frequent ceRNA pair. Among miRNAs, miR-107 played a key role by regulating three different loops. Understanding the various aspects of this regulatory mechanism can help elucidate the unknown etiology of AD and provide new molecular targets for use in therapeutic and clinical applications.Hani SabaieHani SabaieNazanin AmirinejadMohammad Reza AsadiAbbas JalaieiYousef DaneshmandpourOmidvar RezaeiMohammad TaheriMohammad TaheriMaryam RezazadehMaryam RezazadehFrontiers Media S.A.articleAlzheimer’s diseaseantisense oligonucleotidescompeting endogenous RNAlong non-coding RNAmiRNA spongeNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Aging Neuroscience, Vol 13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
antisense oligonucleotides
competing endogenous RNA
long non-coding RNA
miRNA sponge
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Alzheimer’s disease
antisense oligonucleotides
competing endogenous RNA
long non-coding RNA
miRNA sponge
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Hani Sabaie
Hani Sabaie
Nazanin Amirinejad
Mohammad Reza Asadi
Abbas Jalaiei
Yousef Daneshmandpour
Omidvar Rezaei
Mohammad Taheri
Mohammad Taheri
Maryam Rezazadeh
Maryam Rezazadeh
Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review
description Alzheimer’s disease (AD) is a heterogeneous degenerative brain disorder with a rising prevalence worldwide. The two hallmarks that characterize the AD pathophysiology are amyloid plaques, generated via aggregated amyloid β, and neurofibrillary tangle, generated via accumulated phosphorylated tau. At the post-transcriptional and transcriptional levels, the regulatory functions of non-coding RNAs, in particular long non-coding RNAs (lncRNAs), have been ascertained in gene expressions. It is noteworthy that a number of lncRNAs feature a prevalent role in their potential of regulating gene expression through modulation of microRNAs via a process called the mechanism of competing endogenous RNA (ceRNA). Given the multifactorial nature of ceRNA interaction networks, they might be advantageous in complex disorders (e.g., AD) investigations at the therapeutic targets level. We carried out scoping review in this research to analyze validated loops of ceRNA in AD and focus on ceRNA axes associated with lncRNA. This scoping review was performed according to a six-stage methodology structure and PRISMA guideline. A systematic search of seven databases was conducted to find eligible articles prior to July 2021. Two reviewers independently performed publications screening and data extraction, and quantitative and qualitative analyses were conducted. Fourteen articles were identified that fulfill the inclusion criteria. Studies with different designs reported nine lncRNAs that were experimentally validated to act as ceRNA in AD in human-related studies, including BACE1-AS, SNHG1, RPPH1, NEAT1, LINC00094, SOX21-AS1, LINC00507, MAGI2-AS3, and LINC01311. The BACE1-AS/BACE1 was the most frequent ceRNA pair. Among miRNAs, miR-107 played a key role by regulating three different loops. Understanding the various aspects of this regulatory mechanism can help elucidate the unknown etiology of AD and provide new molecular targets for use in therapeutic and clinical applications.
format article
author Hani Sabaie
Hani Sabaie
Nazanin Amirinejad
Mohammad Reza Asadi
Abbas Jalaiei
Yousef Daneshmandpour
Omidvar Rezaei
Mohammad Taheri
Mohammad Taheri
Maryam Rezazadeh
Maryam Rezazadeh
author_facet Hani Sabaie
Hani Sabaie
Nazanin Amirinejad
Mohammad Reza Asadi
Abbas Jalaiei
Yousef Daneshmandpour
Omidvar Rezaei
Mohammad Taheri
Mohammad Taheri
Maryam Rezazadeh
Maryam Rezazadeh
author_sort Hani Sabaie
title Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review
title_short Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review
title_full Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review
title_fullStr Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review
title_full_unstemmed Molecular Insight Into the Therapeutic Potential of Long Non-coding RNA-Associated Competing Endogenous RNA Axes in Alzheimer’s Disease: A Systematic Scoping Review
title_sort molecular insight into the therapeutic potential of long non-coding rna-associated competing endogenous rna axes in alzheimer’s disease: a systematic scoping review
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/a83098d4e64344e19aa3f308ce936fb7
work_keys_str_mv AT hanisabaie molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT hanisabaie molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT nazaninamirinejad molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT mohammadrezaasadi molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT abbasjalaiei molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT yousefdaneshmandpour molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT omidvarrezaei molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT mohammadtaheri molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT mohammadtaheri molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT maryamrezazadeh molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
AT maryamrezazadeh molecularinsightintothetherapeuticpotentialoflongnoncodingrnaassociatedcompetingendogenousrnaaxesinalzheimersdiseaseasystematicscopingreview
_version_ 1718405980225536000